東生華製藥

Home / News

TSH Board of Directors Approved Financial Statements For the Year Ended December 31, 2023

TSH Board of Directors Approved Financial Statements For the Year Ended December 31, 2023

2024.2.27

...

Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO., LTD., regarding the BOD resolved to convene the 2024 Annual General Shareholders' Meeting

Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO., LTD., regarding the BOD resolved to convene the 2024 Annual General Shareholders' Meeting

2024.2.22

...

TSH announces TFDA acceptance TSH announces TFDA acceptance Tyrvaya® for Dry Eye Nasal Spray, expected approval by late 2024.

TSH announces TFDA acceptance TSH announces TFDA acceptance Tyrvaya® for Dry Eye Nasal Spray, expected approval by late 2024.

2024.1.3

...

TSH Biopharm was invited to attend the institutional investor conference hosted by KGI Securities

TSH Biopharm was invited to attend the institutional investor conference hosted by KGI Securities

2023.12.21

...

To announce the change of financial officer and acting spokesperson of the Company

To announce the change of financial officer and acting spokesperson of the Company

2023.12.14

...

To announce the release of non-compete restrictions for managerial officer

To announce the release of non-compete restrictions for managerial officer

2023.12.4

...